STOCK TITAN

Corvus Pharmaceuticals, Inc. (CRVS) Net Income by Year

CRVS

Corvus Pharmaceuticals, Inc. reported a net loss of $15.3M in fiscal year 2025. This represents an increase of 75.4% from the prior fiscal year. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Corvus Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Net Income -$15.3M
YoY +75.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CRVS Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
Net Income-$15.3M+75.4%-$62.3M-130.7%-$27.0M+34.6%-$41.3M+4.5%-$43.2M-621.3%-$6.0M+87.2%-$46.7M+0.6%-$46.9M+15.7%-$55.7M-53.0%-$36.4M-16.1%-$31.3M-19362.7%-$161K

CRVS Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$18.0M-124.5%-$13.7M-190.1%N/A-$10.2M+74.7%-$8.0M-87.7%$15.2M+366.5%N/A-$40.2M-570.3%-$4.3M+34.5%-$5.7M+27.6%N/A-$6.0M+59.5%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Corvus Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Corvus Pharmaceuticals, Inc.'s net income in fiscal year 2025?

Corvus Pharmaceuticals, Inc. reported a net loss of $15.3M in fiscal year 2025.

How fast is Corvus Pharmaceuticals, Inc.'s net income growing?

Corvus Pharmaceuticals, Inc. (CRVS) net income rose by 75.4% year over year, from -$62.3M to -$15.3M in fiscal year 2025.

How has Corvus Pharmaceuticals, Inc.'s net income changed over the years?

Across the 12 fiscal years this page covers, Corvus Pharmaceuticals, Inc. (CRVS) net income went from -$161K in fiscal year 2014 to -$15.3M in fiscal year 2025.

Corvus Pharmaceuticals, Inc. (CRVS) reported -$18.0M in net income in Q2 2026. This represents a decrease of 124.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Corvus Pharmaceuticals, Inc. (CRVS) reported on that line in every period on record.